Announcements Trials
Browse Landscape

Phase

Phase NA 7Phase 2 3Phase 1/2 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Dermatologic 3

Conditions

Melanoma 864Lymphoma, T-Cell, Cutaneous 143Uveal Melanoma 96Skin Neoplasms 96Mycosis Fungoides 95Sezary Syndrome 81Carcinoma, Basal Cell 76Neoplasm Metastasis 68Lymphoma 64Lymphoma, Non-Hodgkin 63Keratosis, Actinic 61Neoplasms 57Leukemia, Lymphocytic, Chronic, B-Cell 57Carcinoma, Renal Cell 55Carcinoma, Non-Small-Cell Lung 54Lymphoma, B-Cell, Marginal Zone 53Precursor Cell Lymphoblastic Leukemia-Lymphoma 52Lymphoma, Mantle-Cell 52Lymphoma, Large B-Cell, Diffuse 52Lymphoma, Follicular 52Hodgkin Disease 52Lymphoma, Large-Cell, Immunoblastic 50Carcinoma, Merkel Cell 50Burkitt Lymphoma 49Brain Neoplasms 46Multiple Myeloma 44Lymphoma, Large-Cell, Anaplastic 41Recurrence 40Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 40Breast Neoplasms 40

Interventions

Diclofenac 2Eflornithine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × Non-melanoma Skin Cancer × Dermatologic × Clear all
NCT02636569 2026-01-21

Topical Chemoprevention of Skin Cancer Biomarkers

University of Alabama at Birmingham

Phase 2 Completed
24 enrolled
Dermatologic

Non-melanoma Skin Cancer

NCT04091022 2025-12-17

Topical Diclofenac and Topical DFMO Chemoprevention Trial in Subjects With a History of Skin Cancer

University of Alabama at Birmingham

Phase 2 Completed
64 enrolled
Dermatologic

Non-melanoma Skin Cancer

NCT02080962 2014-03-07

Hypofractionated Radiotherapy for Nonmelanoma Skin Cancer

Barretos Cancer Hospital

Phase 2 Terminated
10 enrolled
Dermatologic

Non-melanoma Skin Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡